Financhill
Back

Catalyst Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
81

CPRX
Catalyst Pharmaceuticals, Inc.

Last Price:
$24.10
Seasonality Move:
6.75%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Catalyst Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 23.83 Buy
20-day SMA: 23.41 Buy
50-day SMA: 22.32 Buy
200-day SMA: 22.16 Buy
8-day EMA: 23.81 Buy
20-day EMA: 23.39 Buy
50-day EMA: 22.21 Buy
200-day EMA: 13.91 Buy

Catalyst Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.47 Buy
Relative Strength Index (14 RSI): 63.86 Buy
Chaikin Money Flow: 629032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.73 - 23.83) Buy
Bollinger Bands (100): (19.93 - 22.69) Buy

Catalyst Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Catalyst Pharmaceuticals, Inc. Stock

Is Catalyst Pharmaceuticals, Inc. Stock a Buy?

CPRX Technical Analysis vs Fundamental Analysis

Buy
81
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Is Catalyst Pharmaceuticals, Inc. a Buy or a Sell?

Catalyst Pharmaceuticals, Inc. Stock Info

Market Cap:
3B
Price in USD:
24.31
Share Volume:
1.1M

Catalyst Pharmaceuticals, Inc. 52-Week Range

52-Week High:
26.58
52-Week Low:
19.05
Buy
81
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Catalyst Pharmaceuticals, Inc. Share Price Forecast

Is Catalyst Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Catalyst Pharmaceuticals, Inc.

Is Catalyst Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.

Technical Analysis of Catalyst Pharmaceuticals, Inc.

Should I short Catalyst Pharmaceuticals, Inc. stock?

* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.